Biogen's New Alzheimer's Drug Meets Slow Rollout

The drugmaker's revenue from the drug, Aduhelm, was $300,000 in the first full quarter since its approval, a figure well below analyst expectations. Sales could be minimal through the end of the year, the company said.

 
Verizon's Earnings Topped Estimates. Its Stock Is Rising.

The telecom giant showed improving subscriber growth numbers for a second quarter, as well as progress in moving customers to more expensive plans in the 5G era.

 
Novavax Shares Plunge on Report of Covid-19 Vaccine Manufacturing Problems

A report in Politico said the pharmaceutical company was having difficulties manufacturing a Covid-19 vaccine that met regulators' quality standards.

 
Nestlé Sales Buoyed by Coffee, Pet Food

The Swiss company's upbeat quarter provides an early sign that consumer habits acquired during the pandemic, such as drinking more and better quality coffee at home, could continue to benefit it, despite the ongoing challenges of rising input costs and supply-chain snags.

 
Cushman & Wakefield to Buy 40% Stake in Greystone Multifamily Business

The commercial real estate services giant has agreed to pay $500 million for a 40% stake in the rental apartment lending and loan servicing business owned by Greystone, the latest sign of the strength of the rental apartment industry.

 
Abbott Labs Earnings Beat Estimates. Its Stock Is Rising.

Abbott reported an adjusted profit of $1.40 a share, beating forecasts for $0.94 a share.

 
GM CFO Takes Steps to Help Auto Maker Achieve Its 2030 Goals

General Motors' finance chief is working to build out the company's forecasting and planning capabilities to help the car maker achieve its long-term goals and better explain its business transformation to investors.

 
Tesla Poised for Record Quarterly Earnings on Supply-Chain Resilience

Elon Musk's electric-vehicle maker is expected to notch a third consecutive quarterly profit, thanks in part to its ability to navigate persistent global supply-chain disruptions.

 
Micron Plans $150 Billion in Capital, R&D Spending

Chief Executive Sanjay Mehrotra says the Boise, Idaho-based memory-chip maker is seeking clarity on U.S. financial incentives.

 
Rent the Runway Is a Listing to Be Depreciated

The company is the latest to file for a public offering employing both technology and creative accounting.

(END) Dow Jones Newswires

October 20, 2021 09:00 ET (13:00 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.